SWOG S1826: Frontline N-AVD vs BV-AVD in Advanced Hodgkin’s Lymphoma
Switching their focus to the SWOG S1826 clinical trial in Hodgkin’s Lymphoma, Rohit Gosain, MD, Rahul Gosain, MD, and Jonathan Friedberg, MD, MMSc, consider the role of frontline R-AVD versus BV-AVD.
DLBCL: Real-World Use of Frontline Polatuzumab Vedotin Following the POLARIX Trial
Following their discussion on the phase 3 POLARIX trial in DLBCL, Jonathan Friedberg, MD, MMSc, and the Oncology Brothers consider how frontline polatuzumab vedotin will be used in the real-world setting.
POLARIX: Frontline Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
Oncology Brothers Rohit Gosain, MD, and Rahul Gosain, MD, are joined by expert Jonathan Friedberg, MD, MMSc, to review data with frontline polatuzumab vedotin in DLBCL from the phase 3 POLARIX trial.
2 Clarke Drive Cranbury, NJ 08512